Skip to main content
Signal8

PR Newswire press releases

Full-text press releases distributed by PR Newswire, newest first. Times are US Eastern.

Source: PR Newswire

  1. Xinhua Silk Road: Wuliangye explores new paradigm for global branding at panda-themed conference in SW China

    During the Global Panda Partners Conference 2026 held in Sichuan Province, southwest China from November 2 to 4, Chinese baijiu maker Wuliangye well leveraged its "harmony and coexistence"-centric development philosophy to expand its global presence.

  2. Xinhua Silk Road: Overseas media representatives visit Xiaomi's smart auto factory in Beijing

    On November 6, media representatives from various countries and regions visited Xiaomi's smart auto factory in southeast Beijing, exploring firsthand Xiaomi's achievements in NEV R&D, intelligent manufacturing and ecosystem innovation.

  3. Xinhua Silk Road: Overseas media representatives visit Xiaomi's smart auto factory in Beijing

    On November 6, media representatives from various countries and regions visited Xiaomi's smart auto factory in southeast Beijing, exploring firsthand Xiaomi's achievements in NEV R&D, intelligent manufacturing and ecosystem innovation.

  4. FF EAI Robotics Ecosystem Inc. (FFR) and Faraday Future Announce FF OmniMind and Its Model Achieve No. 1 in RoboColiseum Embodied AI Model Ranking; Advance Sales with Several Leading U.S. Integrators of Security and Inspection Robotics Solutions

    $FFR

    FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) ("FFR" or the "Company"), a California-based Physical AI robotics ecosystem company, today shared a weekly business update from YT Jia, Founder and Global CEO of FFR and FF.

  5. GlycoNex Announces Japanese Regulatory Submission for Denosumab Biosimilar SPD8

    GlycoNex, Inc. (TPEx: 4168), a clinical-stage biotechnology company developing glycan-directed antibody-drug conjugates (ADCs), and biosimilars, today announced that a marketing authorization application for SPD8, its denosumab biosimilar candidate co-developed with Mitsubishi Gas Chemical (MGC), has been submitted to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). Subject to regulatory review and approval, SPD8 could receive approval in Japan as early as the end of 2027, paving the way for commercial launch. Preparations for a regulatory submission in Taiwan are also underway.

  6. Stavian Group Showcases Its Infrastructure Vision for the AI Era at the Inaugural Fortune SEA500 Summit 2026

    As Southeast Asia enters a new phase of growth shaped by artificial intelligence, digital transformation, evolving supply chains, and shifting investment flows, businesses are increasingly focused on building the foundations needed to thrive in a more interconnected and technology-driven economy.

  7. LG ELECTRONICS EARNS FIRST ASIL D PRODUCT CERTIFICATION FOR AUTOMOTIVE CENTRAL GATEWAY SYSTEM

    LG Electronics (LG) has earned its first ISO 26262 Automotive Safety Integrity Level D (ASIL D) product certification for its automotive central gateway system, developed as the central communication unit (CCU) 2.0 for the Genesis GV90. The certification, awarded by global testing and certification body TÜV Rheinland, is also the first ASIL D product certification the organization has issued in the automotive central gateway system category.*

  8. Stavian Group Showcases Its Infrastructure Vision for the AI Era at the Inaugural Fortune SEA500 Summit 2026

    As Southeast Asia enters a new phase of growth shaped by artificial intelligence, digital transformation, evolving supply chains, and shifting investment flows, businesses are increasingly focused on building the foundations needed to thrive in a more interconnected and technology-driven economy.

  9. Global Validation First: How CrossHub Is Building Trust to Scale Overseas

    For startups entering foreign markets, proving their technology and turning it into real business is an uphill battle. They must navigate local regulations, understand market demand and win the trust of companies wary of adopting new technology. CrossHub, a developer of identity verification and payment solutions, is tackling these hurdles by running proofs of concept (PoCs) with overseas partners, building a track record, and converting those references into field deployments and partnerships with financial institutions.

  10. Koround Targets Southeast Asia with Halal- and Vegan-Certified K-Beauty

    Competition among K-beauty brands keeps intensifying. Kim Jung-hoon, CEO of Koround (https://koround.com), has chosen a strategy of catching consumers' eyes first and keeping them with proven efficacy. The company is targeting Southeast Asia with DECORE, its clean-beauty skincare brand, using halal and vegan certifications as its edge.

  11. Southeast Asia looks beyond familiar gateways in East Asia, Traveloka platform data shows

    While East Asia is a familiar fixture on Southeast Asia's travel wish list, Traveloka's latest booking data points to a broader set of destinations gaining ground beyond the region's best-known gateways. From Fukuoka's yatai food stalls to Hangzhou's lakeside landscapes, alternative destinations across South Korea, Japan and China are swiftly becoming priorities for Southeast Asian travelers.

  12. Luxury, Your Way: Agoda Explores How the Stay Can Shape the Trip

    $BKNG

    Digital travel platform Agoda highlights potential opportunities for hospitality partners across Asia to connect with travelers through personal expressions of luxury, from distinctive dining to wellness and cultural discovery, against a backdrop of the region's growing affluence. According to Capgemini's World Wealth Report 2026, the region recorded the highest growth in individual wealth in 2025, rising 10.5%, expanding the potential audience for premium stays and experiences. For hospitality partners, understanding what travelers want from each trip can help shape offerings that make their stays memorable.

  13. Timing Affects Speed, Not Total Exposure

    Clopidogrel does not work the same way in every patient. In East Asian populations the gap is wider still: a share of patients get too little platelet inhibition at the standard dose, and some get none. Effective antiplatelet therapy carries its own price, because the harder platelets are suppressed, the greater the risk of bleeding, and physicians must strike that balance every day. In acute ischaemic stroke the clock runs in hours, and today's antiplatelet drugs are not called on to be both fast and safe. Roughly 40% of stroke patients also arrive unable to swallow, and there is still no injectable option for them. Each of these problems comes back to one question: can the way a drug is absorbed, and how quickly it starts working, be counted on?

  14. Antengene Presents Latest Preclinical Results of Novel Cos-TCE Platform AnTenGager‑D2 in Rapid Oral Abstract Presentation at SITC 2026

    Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune diseases, solid tumors and hematological malignancies, today announced that it has presented the latest preclinical results of its novel costimulatory T cell engager (Cos-TCE) platform AnTenGager‑D2 in a Rapid Oral Abstract Presentation at the 2026 Society for Immunotherapy of Cancer Annual Meeting (SITC 2026). The study was selected as TOP150 abstracts by the conference.

  15. Antengene Presents Latest Preclinical Results of Novel Cos-TCE Platform AnTenGager‑D2 in Rapid Oral Abstract Presentation at SITC 2026

    Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune diseases, solid tumors and hematological malignancies, today announced that it has presented the latest preclinical results of its novel costimulatory T cell engager (Cos-TCE) platform AnTenGager‑D2 in a Rapid Oral Abstract Presentation at the 2026 Society for Immunotherapy of Cancer Annual Meeting (SITC 2026). The study was selected as TOP150 abstracts by the conference.

  16. Innovent Announces Phase 3 CREDIT-5 Study Met Primary Endpoint, SINTBILO® (Tafolecimab Injection) as First-line Monotherapy Treatment for Hyperlipidemia Demonstrated Potent Lipid-lowering Efficacy

    Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic and other major diseases, announced today that its self-developed recombinant fully human anti-proprotein convertase subtilisin/kexin 9 (PCSK9) monoclonal antibody, SINTBILO® (tafolecimab injection, R&D code: IBI306), has achieved its primary endpoint at week 12 in the multi-center, randomized, double-blind, placebo-controlled monotherapy Phase 3 clinical study (CREDIT-5) in Chinese participants with non-familial hypercholesterolemia and mixed hyperlipidemia. In this study, SINTBILO®  (tafolecimab injection) monotherapy showed significant lipid-lowering efficacy with favorable safety and tolerability.

  17. Trip.com Turns Up the Savings this November with Mega Deals on Flights, Hotels and More in Australia

    November isn't just for shopping carts – it's for packing suitcases for Christmas too! Trip.com is giving Aussie travellers plenty of reasons to plan their next getaway, with its Black Friday Mega Sale bringing together a line-up of travel deals across 11.11 and Black Friday.

  18. Rosen Law Firm Encourages Fervo Energy Company Investors to Inquire About Securities Class Action Investigation - FRVO

    $FRVO

    Rosen Law Firm Encourages Fervo Energy Company Investors to Inquire About Securities Class Action Investigation - FRVO

  19. NCPL Investors Have Opportunity to Lead Netcapital Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm

    $NCPL

    NCPL Investors Have Opportunity to Lead Netcapital Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm

  20. Roche opens up new possibilities for genomic research in Asia Pacific with next-generation sequencing technology

    $RHHBY

    Roche is advancing its next-generation sequencing (NGS) ambitions in Asia Pacific following the global launch of AXELIOS 1 in June 2026. Building on early adoption in South Korea, Roche will bring the transformative technology closer to researchers and laboratory leaders across the region through AXELIOS Days in Sydney and Seoul this November.

  21. Momcozy Unlocks Easier Motherhood with Black Friday Deals for Australian Mums

    Motherhood is full of meaningful moments, but the everyday routines behind them aren't always easy. This Black Friday, Momcozy brings moms a few helpful "Cheat Codes," with up to 25% OFF on official online store and Amazon, from November 17–25, helping Australian parents make everyday parenting a little easier.

  22. Fibocom LTE Cat.1 bis Modules: Starlink DTC Field Test Report

    Fibocom's LE270-EU and LE271-GL LTE Cat.1 bis modules have successfully connected to the SpaceX Direct to Cell (DTC) satellite network during live-network testing in New Zealand. Using standard firmware and without adding satellite-specific hardware modifications, both modules successfully registered on the network, established IP data sessions, and transmitted data over the satellite link. Testing across outdoor, in-vehicle, and indoor environments also provided insights into real-world connectivity performance under different conditions.

  23. Rosen Law Firm Encourages J.B. Hunt Transport Services, Inc. Investors to Inquire About Securities Class Action Investigation - JBHT

    $JBHT

    Rosen Law Firm Encourages J.B. Hunt Transport Services, Inc. Investors to Inquire About Securities Class Action Investigation - JBHT

  24. BULL Investors Have Opportunity to Lead Webull Corporation Securities Fraud Lawsuit Filed by The Rosen Law Firm

    $BULL

    BULL Investors Have Opportunity to Lead Webull Corporation Securities Fraud Lawsuit Filed by The Rosen Law Firm

  25. Novo post hoc analysis finds Wegovy® 2.4 mg was associated with improvements in liver markers in adults with MASH with liver scarring and a BMI less than 27 kg/m2, presented at The Liver Meeting® (AASLD) 2026

    Today, Novo Nordisk announced results from a post hoc analysis of the phase 3 ESSENCE trial. The analysis included a subgroup of 106 adults with metabolic dysfunction-associated steatohepatitis (MASH) and liver scarring who had a BMI below 27 kg/m². At week 72, multiple liver-related measures improved among participants receiving once-weekly semaglutide 2.4 mg injection compared with placebo, including liver enzymes and non-invasive markers of disease activity and fibrosis. Results were presented in an oral presentation at The Liver Meeting® 2026 in Denver, Colorado.1

  26. Webull Corporation (BULL) Class Action Lawsuit: Investors Face December 7, 2026, Deadline - Kessler Topaz Meltzer & Check, LLP

    $BULL

    Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against Webull Corporation ("Webull") (NASDAQ: BULL) on behalf of those who purchased or acquired Webull securities between April 26, 2025 and October 6, 2026, inclusive. The lawsuit is filed in the United States District Court for the Middle District of Florida and is captioned Ward v. Webull Corporation, No. 8:26-cv-03052 (M.D. Fla.).  Investors have until December 7, 2026, to file for lead plaintiff status.

  27. Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA

    $AZTA

    Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA

  28. Allergan Aesthetics Reports Improved Satisfaction With Facial Appearance Following Aesthetic Treatment in Two Studies of Patients on GLP-1 Medications

    $ABBV

    Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced results from HARMONY IN DIVERSITY and HALO, two Phase 4 studies of aesthetic treatment in adults on glucagon-like peptide-1 (GLP-1) medications. HARMONY IN DIVERSITY is the first study to evaluate a neurotoxin combined with hyaluronic acid (HA) injectables in this population. In its medical weight loss cohort, participants reported statistically significant improvements in satisfaction with facial appearance and skin quality, as well as psychological and social function, following treatment with HA injectables, a neurotoxin and a study-specified skincare regimen. HALO interim results showed high patient satisfaction following HA injectable treatment. The data were presented at the 2026 American Society for Dermatologic Surgery (ASDS) Annual Meeting, Nov. 5-8 in San Diego.

  29. KeyStone Solutions Wins 2026 MSP 501 Vanguard Award for Innovation

    KeyStone Solutions, LLC has won the 2026 MSP 501 Vanguard Award from Channel Partners and MSP Summit. The award was presented Sept. 30 at the MSP 501 Gala during the MSP Summit in Orlando, Fla.

  30. ASTS Deadline in 5 Days: AST SpaceMobile, Inc. Securities Fraud Class Action Lawsuit Filed; November 13, 2026, Lead Plaintiff Deadline - Kessler Topaz Meltzer & Check, LLP

    $ASTS

    Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against AST SpaceMobile, Inc. (AST) (NASDAQ: ASTS) on behalf of those who purchased or acquired AST securities between March 4, 2025 and July 15, 2026, inclusive. The lawsuit is filed in the United States District Court for the Western District of Texas and is captioned Hunter v. AST SpaceMobile, Inc., No. 7:26-cv-00378 (W.D. Tex.). Investors have until November 13, 2026, to file for lead plaintiff status.

  31. Cleaner Bedroom Air May Help Manage Blood Sugar in Prediabetes

    Using portable filters to reduce exposure to air pollution during sleep may stabilize the large spikes in blood sugar experienced by people with prediabetes, a condition in which sugar (glucose) levels are higher than normal, a new study shows.

  32. Amplifon Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Social Security Numbers and Health Records Are Exposed

    Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from a data breach at Amplifon (USA), Inc., the Minneapolis-based U.S. arm of Milan-headquartered Amplifon that administers hearing-care benefit programs for health plans and employers and operates retail hearing networks. Anyone who received a breach notice or believes their information may have been exposed can request a free case evaluation.

  33. Johnson & Johnson reports 73% PSA response rate with investigational pasritamig-based immunotherapy combination in advanced prostate cancer

    $JNJ

    Johnson & Johnson (NYSE: JNJ) today announced promising first-in-human Phase 1 results for the investigational combination of pasritamig and JNJ-9401, two bispecific antibodies designed to work together to drive the body's immune response against advanced prostate cancer. At the recommended regimen, 73 percent (11 of 15 patients) achieved reductions of at least 50 percent in prostate-specific antigen (PSA), a marker used to monitor prostate cancer activity, including 47 percent (7 of 15 patients) who achieved reductions of at least 90 percent. Results were presented in a late-breaking oral session at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting (Abstract #1175).1

  34. LifeBiotic Launches Randomized Phase 2 Trial of Botanical Drug Candidate for Bladder Cancer Recurrence Prevention

    For many bladder cancer patients, removing the first tumor is only the beginning. The disease can return repeatedly, requiring additional surgeries, treatments and years of medical surveillance.

  35. GIL INVESTOR NOTICE: Gildan Activewear Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before December 14, 2026 Deadline

    $GIL

    The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Gildan Activewear Inc. (NYSE: GIL) publicly traded securities between February 19, 2025 and June 15, 2026, both dates inclusive (the "Class Period"), have until Monday, December 14, 2026 to seek appointment as lead plaintiff of the Gildan Activewear class action lawsuit.  Captioned Cortez v. Gildan Activewear Inc., No. 26-cv-02126 (N.D.N.Y.), the Gildan Activewear class action lawsuit charges Gildan Activewear and certain of Gildan Activewear's top current and former executives with violations of the Securities Exchange Act of 1934.

  36. D-Wave Quantum Inc. (QBTS) Investors: December 15, 2026, Deadline in Securities Fraud Class Action Lawsuit - Kessler Topaz Meltzer & Check, LLP

    $QBTS

    Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against D-Wave Quantum Inc. (D-Wave) (NASDAQ: QBTS) on behalf of those who purchased or acquired D-Wave securities between February 26, 2026 and August 25, 2026, inclusive. The lawsuit is filed in the United States District Court for the Northern District of California and is captioned Fessler v. D-Wave Quantum Inc., No. 5:26-cv-11953 (N.D. Cal.).  Investors have until December 15, 2026, to file for lead plaintiff status.

  37. ENSG Investors Have Opportunity to Lead The Ensign Group, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm

    $ENSG

    ENSG Investors Have Opportunity to Lead The Ensign Group, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm

  38. Bridgeton Auto Mall Launches Repair for Life: Every Qualifying Repair Now Backed by a Parts and Labor Warranty

    Bridgeton Auto Mall has launched its Repair for Life program, adding a limited parts and labor warranty to qualifying customer-pay repairs in its service department. Under the program, when a customer pays for a repair, that repair is backed by the Repair Forever™ Limited Warranty on the parts and labor involved — coverage that lasts for as long as the customer owns the vehicle. Pay for the repair once, and it stays covered. If a covered part fails again, the customer does not pay for that part or the labor to repair it again, provided they return to Bridgeton Auto Mall for the work. And it does not matter where the vehicle was bought — whether a customer bought their car at Bridgeton Auto Mall or elsewhere, Repair for Life is here for them.

  39. Putting Young Innovators Center Stage: Leaders In Future Tech+ Wraps with ¥526 Million in Investment Intentions and 31 Enterprise Landings

    On November 7, the grand finale of Leaders In Future Tech+ — a documentary sci-tech innovation program jointly produced by China Media Group, the Ministry of Education, and the Nanjing Municipal People's Government — aired as the Youth Innovation Carnival.

  40. GSMA MWC26 Doha opens with call to align on global industry standards and close MENA's connectivity gap

    MWC26 Doha, held in partnership with Qatar's Ministry of Communications and Information Technology (MCIT), opened today at Doha Exhibition and Convention Centre (DECC), bringing together connectivity ecosystem to shape the next phase of growth for a mobile economy forecast to add $470 billion to the Middle East and North Africa by 2030.

  41. GSMA MWC26 Doha opens with call to align on global industry standards and close MENA's connectivity gap

    MWC26 Doha, held in partnership with Qatar's Ministry of Communications and Information Technology (MCIT), opened today at Doha Exhibition and Convention Centre (DECC), bringing together connectivity ecosystem to shape the next phase of growth for a mobile economy forecast to add $470 billion to the Middle East and North Africa by 2030.

  42. Club Offers for Travel Enthusiasts in Germany

    $TZOO

    Travelzoo® (NASDAQ: TZOO), the club for travel enthusiasts, announces five of many new Club Offers for Club Members in Germany.

  43. 2026 China International Intelligent Communication Forum Held in Wuxi

    From November 8 to 10, the 2026 China International Intelligent Communication Forum (CIICF), jointly organized by China Media Group (CMG) and the Jiangsu Provincial People's Government, is held in Wuxi, Jiangsu Province.

  44. 2026 China International Intelligent Communication Forum Held in Wuxi

    From November 8 to 10, the 2026 China International Intelligent Communication Forum (CIICF), jointly organized by China Media Group (CMG) and the Jiangsu Provincial People's Government, is held in Wuxi, Jiangsu Province.

  45. "Pulse @ Jurong" launches as a New Digital Community Platform connecting Everyday Life across Singapore's West

    Pulse @ Jurong, a new community-centric digital platform developed by Jurong Point and Link Asset Management, has officially launched to bring everyday life across Singapore's West closer together. Designed around the needs of residents, workers, students and visitors, the app connects transport information, neighbourhood businesses, local dining and retail offers, community activities and essential amenities in one convenient platform.

  46. Club Offers for Travel Enthusiasts in Canada

    $TZOO

    Travelzoo® (NASDAQ: TZOO), the club for travel enthusiasts, announces five of many new Club Offers for Club Members in Canada.

  47. Club Offers for Travel Enthusiasts in the U.S.

    $TZOO

    Travelzoo® (NASDAQ: TZOO), the club for travel enthusiasts, announces six of many new Club Offers for Club Members in the U.S.

  48. Big on Savings, Big on Happy with Cebu Pacific's 11.11 Seat Sale

    Cebu Pacific (PSE: CEB), the Philippines' leading carrier, is offering big savings on 2027 travel with its 11.11 Super Seat Fest, putting a Philippine getaway within easier reach for international travelers.

  49. TCL CSOT to Explore the Future of Displays in the AI Era at DTC 2026

    The TCL CSOT Global Display Tech-Ecosystem Conference 2026 (DTC 2026) will take place in Wuhan, China, on November 13. Under the theme "TRUE VISION, AI IN MOTION," this year's conference will present TCL CSOT's latest advances in Inkjet Printing OLED (IJP OLED), APEX display technologies, AI applications, and next-generation display solutions.

Source: PR Newswire

Content provided by PR Newswire. Redistribution, resale or sublicensing is not permitted.

    PR Newswire press releases | Signal8